source
- STAT+: Supreme Court rejects challenge to Medicare drug price negotiationThe rejection may make the pharma firms remaining lawsuits more difficult.STAT · 2mo ago↗ source
- The Supreme Court won't take up drugmakers' IRA casesThe Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca,…Endpoints · 2mo ago↗ source
- STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreThe question of whether to partner with Chinese firms — or see them as rivals — is tearing biotech apart, pitting peers and partners against one anotherSTAT · 2mo ago↗ source